Trials / Sponsors / Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer | Phase 1 | 2026-03-15 |
| Recruiting | Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants W Endometrial Cancer, Ovarian Cancer, Ovarian Cancer Metastatic | Phase 1 | 2025-12-19 |